- Home
- RIBB vs ELUT Comparison
RIBB vs ELUT Comparison
Compare RIBB & ELUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RIBB
- ELUT
- Stock Information
- Founded
- RIBB 2024
- ELUT 2015
- Country
- RIBB Japan
- ELUT United States
- Employees
- RIBB N/A
- ELUT 51
- Industry
- RIBB
- ELUT Medical Specialities
- Sector
- RIBB
- ELUT Health Care
- Exchange
- RIBB NYSE
- ELUT Nasdaq
- Market Cap
- RIBB 64.9M
- ELUT 85.5M
- IPO Year
- RIBB 2025
- ELUT 2020
- Fundamental
- Price
- RIBB $10.15
- ELUT $2.38
- Analyst Decision
- RIBB
- ELUT Strong Buy
- Analyst Count
- RIBB 0
- ELUT 2
- Target Price
- RIBB N/A
- ELUT $8.00
- AVG Volume (30 Days)
- RIBB 11.9K
- ELUT 26.5K
- Earning Date
- RIBB 01-01-0001
- ELUT 08-06-2025
- Dividend Yield
- RIBB N/A
- ELUT N/A
- EPS Growth
- RIBB N/A
- ELUT N/A
- EPS
- RIBB N/A
- ELUT N/A
- Revenue
- RIBB N/A
- ELUT $23,711,000.00
- Revenue This Year
- RIBB N/A
- ELUT $20.10
- Revenue Next Year
- RIBB N/A
- ELUT $85.89
- P/E Ratio
- RIBB N/A
- ELUT N/A
- Revenue Growth
- RIBB N/A
- ELUT N/A
- 52 Week Low
- RIBB $9.95
- ELUT $1.61
- 52 Week High
- RIBB $10.45
- ELUT $5.12
- Technical
- Relative Strength Index (RSI)
- RIBB N/A
- ELUT 69.40
- Support Level
- RIBB N/A
- ELUT $2.08
- Resistance Level
- RIBB N/A
- ELUT $2.23
- Average True Range (ATR)
- RIBB 0.00
- ELUT 0.19
- MACD
- RIBB 0.00
- ELUT 0.07
- Stochastic Oscillator
- RIBB 0.00
- ELUT 81.52
About RIBB RIBBON ACQUISITION CORP
Ribbon Acquisition Corp is a blank check company.
About ELUT Elutia Inc.
Elutia Inc Formerly Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. The company's segments include Device Protection, Women's Health and Cardiovascular. It generates maximum revenue from the Women's Health segment. The products of the company are targeted to address unmet clinical needs with the goal of promoting healthy tissue formation and avoiding complications associated with medical device implants, such as scar-tissue formation, capsular contraction, erosion, migration, non-union of implants and implant rejection.